Thursday - March 5, 2026
Patient with melanoma receives tumor-infiltrating lymphocyte therapy
February 18, 2026
NASHVILLE, Tennessee, Feb. 18 -- Vanderbilt University Medical Center issued the following news release:

* * *

Patient with melanoma receives tumor-infiltrating lymphocyte therapy

*

Vanderbilt-Ingram Cancer Center has treated its first patient in a newly launched therapy program that magnifies the power of a person's natural defense system against tumors.

Tumor-infiltrating lymphocyte (TIL) therapy involves isolating the whit . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products